DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Tottenham Hotspur Football Club Joe Lewis - 1 Lewis - 1 Joe Lewis - 1 Jessica Clarke - 1 Mr - 1 Mark Herr - 1 Prosecutors - 1 Boxer Capital - 1
Top related locs:
New York City U.S Manhattan London's Bahamas Broad Bay London New York
Top related orgs:
Tottenham Hotspur Football Club - 1 US - 1 Office - 1 Southern - 1 of New York - 1 Tavistock Group - 1 Aviva - 1 London's Tottenham Hotspur - 1

Search resuls for: "Boxer Capital"


2 mentions found


☆ British billionaire Joe Lewis fined $5 million by U.S. judge for insider trading
  + stars: | 2024-04-04 | by ( ) www.cnbc.com   time to read: +3 min
British billionaire and former owner of the Tottenham Hotspur Football Club Joe Lewis arrives at federal court for his sentencing in an insider trading case on April 4, 2024, in New York City. U.S. District Judge Jessica Clarke in Manhattan sentenced Lewis, who pleaded guilty in January to one count of conspiracy and two counts of securities fraud. Lewis in January entered a plea deal with prosecutors agreeing to a $50 million fine of his Bahamas company, Broad Bay. Under the agreement, Lewis' fine will be included in the total. Lewis has since remained in the country, posting $300 million bail secured by his yacht and a private aircraft.
Persons: Tottenham Hotspur Football Club Joe Lewis, Lewis, Joe Lewis, Jessica Clarke, Mr, Mark Herr, Prosecutors, Boxer Capital, Patrick O'Connor, Bryan Waugh Organizations: Tottenham Hotspur Football Club, US, Office, Southern, of New York, Tavistock Group, Aviva, London's Tottenham Hotspur, Boxer, Forbes, Prosecutors, Mirati Therapeutics, Boxer Capital, Tango Therapeutics Locations: New York City, U.S, Manhattan, London's, Bahamas, Broad Bay, London, New York
☆ Only a handful of psychedelics companies have gotten funding from established biotech investors. Here's what they've done right, according to a top VC.
  + stars: | 2022-11-22 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +4 min
RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The number of companies touting the benefits of psychedelics for healthcare is rapidly growing, but not all biotech investors are on board yet. Last year RA Capital made two investments into the psychedelics spaceIn 2021, RA made its first investments into the psychedelics space by funding two startups: GH Research and Delix Therapeutics. Dublin, Ireland-based GH Research is one of the only psychedelics companies to have garnered a flurry of interest from mainstream healthcare investors including RA Capital, RTW Investments, and BVF Partners. Lusaris' treatment is designed to be taken sublingually — placed under the tongue — for treatment-resistant depression.
0 next >>
Total: 2